The World Health Organization (WHO) is introducing updated recommendations aimed at dramatically improving tuberculosis (TB) testing globally, with a focus on expanding access, reducing costs, and accelerating diagnosis. These changes arrive as TB remains a leading infectious killer, responsible for an estimated 1.3 million deaths in 2022, according to the WHO. Timely and accurate diagnosis is crucial to controlling the spread of the disease and improving patient outcomes, yet reliable testing remains a significant challenge, particularly in low- and middle-income countries.
The new guidance centers on three key innovations: the adoption of near point-of-care molecular tests, the use of tongue swabs as an alternative to traditional sputum samples, and a strategy called sputum pooling. These approaches represent a shift towards more accessible, efficient, and patient-friendly TB testing methods, potentially reaching those previously underserved by existing diagnostic infrastructure.
Expanding Access with Point-of-Care Molecular Tests
For years, diagnosing TB has often required sending samples to centralized laboratories, a process that can be slow, expensive, and logistically difficult, especially in remote areas. The WHO now recommends a new class of near point-of-care (NPOC) molecular tests for the initial detection of TB. These tests can be deployed in decentralized settings like primary healthcare centers and community facilities, bringing diagnostics closer to the patient. These tests offer faster results than traditional methods, often within hours, allowing for quicker treatment initiation.
These molecular tests work by detecting the genetic material of the TB bacteria, offering a high degree of accuracy. The WHO emphasizes that these tests are designed to be more affordable than many existing laboratory-based diagnostics, addressing a critical barrier to widespread screening and diagnosis. The organization is working to facilitate access to these technologies, recognizing that implementation will require investment in training and infrastructure.
Tongue Swabs: A More Acceptable Sample Collection Method
One of the biggest hurdles in TB diagnosis is obtaining a suitable sample. Traditionally, this involves collecting sputum – mucus brought up from the lungs – which can be difficult for many patients, particularly children, the elderly, and those with weakened immune systems. The WHO’s updated guidance introduces tongue swabs as a viable alternative. Unlike sputum, tongue swabs are easy to collect and generally more acceptable to patients.
Research suggests that tongue swabs can be particularly effective in identifying TB in individuals who are unable to produce sputum, expanding testing access among adults and adolescents. While not a replacement for sputum analysis in all cases, the WHO believes tongue swabs will significantly improve case detection rates, especially in community-based settings where traditional sample collection is challenging. The WHO acknowledges that further research is ongoing to optimize the use of tongue swabs in different populations and settings.
Sputum Pooling: Increasing Efficiency and Reducing Costs
In settings with limited resources and high TB burdens, laboratory capacity can be stretched thin. To address this, the WHO is recommending the use of sputum pooling. This involves combining multiple sputum samples and testing them together as a single batch. If the pooled sample tests positive, individual samples are then tested to identify the positive cases.
Sputum pooling can significantly reduce the cost per test and improve laboratory efficiency, allowing for a higher testing throughput. This is particularly valuable in countries with limited diagnostic resources, enabling faster diagnosis and treatment initiation for more individuals. Yet, the WHO stresses that sputum pooling must be implemented carefully, with appropriate quality control measures to ensure accurate results. The optimal number of samples to pool will vary depending on the prevalence of TB in the population being tested.
Supporting Global Implementation
The WHO plans to release a comprehensive update to its tuberculosis diagnosis guidelines later in 2026. This will be accompanied by an operational handbook and implementation toolkit, providing practical guidance for countries looking to adopt these new testing approaches. The toolkit will cover aspects such as planning, training, quality assurance, and monitoring.
To further support implementation, the WHO will also host webinars and maintain an updated knowledge-sharing platform. This platform will serve as a central hub for national TB programs to exchange experiences, best practices, and lessons learned. The organization is committed to providing ongoing technical assistance to countries as they integrate these innovations into their existing healthcare systems.
These recommendations represent a significant step forward in the fight against tuberculosis, offering scalable and accessible solutions to improve detection and reduce the global burden of disease. The success of these initiatives will depend on sustained investment, strong political commitment, and effective collaboration between national governments, international organizations, and healthcare providers. The WHO’s next major update on TB diagnostics is expected in late 2026, providing further details on implementation strategies and monitoring frameworks.
Disclaimer: The information provided in this article is for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
What do you suppose about these new approaches to TB testing? Share your thoughts in the comments below.
